Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial.

@article{Sheashaa2003BasiliximabRT,
  title={Basiliximab reduces the incidence of acute cellular rejection in live-related-donor kidney transplantation: a three-year prospective randomized trial.},
  author={Hussein Attia Sheashaa and Mohamed Adel Bakr and Amany M. Ismail and Mohamed Abdel-Kader Sobh and Mohamed A Ghoneim},
  journal={Journal of nephrology},
  year={2003},
  volume={16 3},
  pages={393-8}
}
BACKGROUND The aim of this work was to investigate the benefit of basiliximab induction therapy in living-related-donor kidney transplantation. METHODS One hundred adult recipients of a first kidney allograft were randomized into two treatment groups, one to receive basiliximab and the second as a control. All patients received maintenance triple immunosuppressive therapy (steroids, cyclosporine microemulsion and azathioprine). The patients were followed up for a minimum of three years. The… CONTINUE READING

From This Paper

Topics from this paper.
11 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…